Long-acting medication, Vyvanse, has received Health Canada approval for use in all age groups. Until now, it was officially approved for children only in Canada.
The starting dose is 20-30mg and the maximum Health Canada sanctioned dose for all ages is 60mg. CADDRA recommends off-label use of up to 60mg in children, up to 70mg in adolescents and adults.
The website is hand-crafted in ZippyHippo online marketing studio.